Cargando…

Underreporting and Triggering Factors for Reporting ADRs of Two Ophthalmic Drugs: A Comparison between Spontaneous Reports and Active Pharmacovigilance Databases

(1) Aims of the study: calculating the underreporting ratio for two different medications, a fixed combination of 0.5% timolol + 0.2% brimonidine + 2.0% dorzolamide (antiglaucoma) and a fixed combination of sodium hyaluronate 0.1% + chondroitin sulfate 0.18% (artificial tears) for characterizing the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Contreras-Salinas, Homero, Baiza-Durán, Leopoldo Martín, Bautista-Castro, Manuel Alejandro, Alonso-Rodríguez, Diego Rodrigo, Rodríguez-Herrera, Lourdes Yolotzin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690340/ https://www.ncbi.nlm.nih.gov/pubmed/36360523 http://dx.doi.org/10.3390/healthcare10112182

Ejemplares similares

Active Pharmacovigilance in Peruvian Population: Surveillance of a Timolol/Brimonidine/Dorzolamide Ophthalmic Fixed Combination
por: Contreras-Salinas, Homero, et al.
Publicado: (2021)

Ophthalmic Solution Safety Profile: Active Surveillance of a Sodium Hyaluronate/Chondroitin Sulfate Combination in Peruvian Population
por: Contreras-Salinas, Homero, et al.
Publicado: (2021)

A Drug Safety Surveillance Study of a Ciprofloxacin/Dexamethasone Ophthalmic Fixed Combination in Peruvian Population
por: Contreras-Salinas, Homero, et al.
Publicado: (2021)

Real-Life Active Surveillance of a Naphazoline/ Hypromellose Fixed Combination’s Safety Profile in Peruvian Population
por: Contreras-Salinas, Homero, et al.
Publicado: (2021)

Ocular Cyclopentolate: A Mini Review Concerning Its Benefits and Risks
por: Contreras-Salinas, Homero, et al.
Publicado: (2022)

Correlation versus Causation? Pharmacovigilance of the Analgesic Flupirtine Exemplifies the Need for Refined Spontaneous ADR Reporting
por: Anderson, Nora, et al.
Publicado: (2011)

Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports
por: Leitzen, Sarah, et al.
Publicado: (2022)

Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System
por: Scavone, Cristina, et al.
Publicado: (2020)

Adverse Drug Reactions (ADR) in the inPatients of Medicine Department of a Rural Tertiary Care Teaching Hospital and Influence of Pharmacovigilance in Reporting ADR
por: Gor, A.P., et al.
Publicado: (2008)

The need for pharmacovigilance in ophthalmic practice
por: Natarajan, Sundaram
Publicado: (2016)

Reexamining Ophthalmic Drugs, Safety and Tolerability in Phase 1 Clinical Trials
por: Muñoz-Villegas, Patricia, et al.
Publicado: (2021)

Are we pharmacovigilant enough in ophthalmic practice?
por: Dubey, Ashok, et al.
Publicado: (2013)

Reported ADRs with chloroquine or hydroxychloroquine
Publicado: (2021)

Efficacy and Safety of an Ophthalmic DMPC-Based Nanoemulsion in Patients with Dry Eye Disease: A Phase I/II Randomized Clinical Trial
por: Baiza-Durán, Leopoldo M., et al.
Publicado: (2023)

PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System
por: Ivos, R., et al.
Publicado: (2021)

Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection
por: Pacurariu, Alexandra C., et al.
Publicado: (2015)

Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs
por: Aagaard, Lise, et al.
Publicado: (2009)

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS)
por: Chiappini, Stefania, et al.
Publicado: (2022)

Incidence and risk factors of adverse drug reactions in patients with coronavirus disease 2019: A pharmacovigilance experience utilizing an ADR trigger tool
por: Alshehail, Bashayer, et al.
Publicado: (2022)

Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports
por: Klein, Kevin, et al.
Publicado: (2015)

Network Characteristic Analysis of ADR-related Proteins and Identification of ADR-ADR Associations
por: Chen, Xiujie, et al.
Publicado: (2013)

Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting
por: Hadi, Muhammad Abdul, et al.
Publicado: (2017)

Pharmacovigilance and spontaneous adverse drug reaction reporting: Challenges and opportunities
por: Desai, Mira
Publicado: (2022)

The Impact of Duration of Treatment on Reported Time-to-Onset in Spontaneous Reporting Systems for Pharmacovigilance
por: Karimi, Ghazaleh, et al.
Publicado: (2013)

Comparative evaluation of adverse drug reaction reporting forms for introduction of a spontaneous generic ADR form
por: Singh, Anshi, et al.
Publicado: (2012)

Impact of pharmacist recruitment on ADR reporting: Malaysian experience
por: Hadi, Muhammad Abdul, et al.
Publicado: (2011)

MHRA COVID-19 website for reporting ADRs and incidents
Publicado: (2020)

Multidisciplinary approach to improve spontaneous ADR reporting in the pediatric outpatient setting: a single-institute experience in Korea
por: Baek, Hyun Jeong, et al.
Publicado: (2016)

Assessment of TB underreporting by level of reporting system in Lagos, Nigeria
por: Gidado, M., et al.
Publicado: (2022)

How to improve suspected ADR reporting among pharmacists in the GCC?
por: Wilbur, Kerry
Publicado: (2016)

Quality of ADR reporting evaluated for remdesivir trials of COVID-19
Publicado: (2020)

Validation of a preclinical dry eye model in New Zealand white rabbits during and following topical instillation of 1% ophthalmic atropine sulfate
por: Sánchez‐Ríos, Alejandra, et al.
Publicado: (2022)

Evaluation of the Rheological Properties, Preclinical Safety, and Clinical Effectiveness of a New Dispersive Ophthalmic Viscoelastic Device for Cataract Surgery
por: Palacio-Pastrana, Claudia, et al.
Publicado: (2022)

Current status of the spontaneous reporting and classification/coding system for herbal and traditional medicine in pharmacovigilance
por: Kim, Mikyung, et al.
Publicado: (2021)

Quality of Spontaneous Reports of Adverse Drug Reactions Sent to a Regional Pharmacovigilance Unit
por: Salvador, Mário Rui, et al.
Publicado: (2022)

SAT-578 Hashimoto's Encephalopathy: An Underreported Syndrome: A Case Report
por: Amin, Hina, et al.
Publicado: (2019)

Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system
por: Filippi-Arriaga, Francesca, et al.
Publicado: (2023)

Sex differences in ADR reports for drugs used to treat COVID-19
Publicado: (2020)

Corns in scleroderma: An underreported entity
por: Chathra, Namitha, et al.
Publicado: (2017)

Syphilis in Poland is on the rise and underreported
por: Teter, Zbigniew, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dhbi936g39j37g6ansmmkjmhq3